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INTRODUCTION:

Picture 1: The chemical structure of tetrahydrofolate and its various
derivaives.( Mark Lucock, et al, 2000)
Folate is the generic term for a large family of similar chemicals. As picture 1
shows, native folates can have different oxidation state. Since native folates can
have many structural forms of folyl-coenzymes, it can be difficult to elucidate
how the folate derivatives inerconvert and how these folate derivatives function
in folate biochemistry.( Mark Lucock, et al,2000)
Human cannot synthesize folate, so, we need to consume a variety of dietary
sources for the uptake of folates. Yeast extracts such as Marmite, liver, kidney,
leafy green vegetables, and citrus fruit are the rich sources containing folates.
On the other hand, if we consume large amounts of moderate sources of the
folates, such as bread, potatoes, and dairy products, it will actually provide a
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significant contribution to the total folate intake, especially since the
fortification of these foods with supplemental folate began in 1998. (Mark
Lucock, et al, 2000)
Food folates exist mainly as 5-methyltetrahydrofolate (5-methyl-H4PteGlun)
and formyltetrahydrofolate (formyl-H4PteGlun) (Ratanasthien K, et al, 1977).
However, 5-Methyl-H4PteGlun is the predominant food folate compared with
formyl-H4PteGlun (Stokstad ELR, et al, 1967; Butterworth CE, et al, 1963) and
it

will

be

easily

(5-methyl-5,6-H2PteGlun)

oxidized

to

(Donaldson

KO,

5-methyl-5,6-dihydrofolate
et

al,

1962).

So

that

5-methyl-5,6-H2PteGlun can also represent a substantial amount of the total
food folate (Ratanasthien K, et al, 1977).
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picture 2: Folate-depend one-carbon metabolism pathway.
As picture 2 shows, folates carry one-carbon units that exist at various levels
of oxidation for three major metabolic roles: synthesis of thymidylate,
methionine, and purine, conversion of serine to glycine, and homocysteine
remethylation cycle. Since these reactions involve various electron transfer steps,
specific folate metabolism enzyme and coenzymes such as FADH2 and NADPH
will be necessary.( Mark Lucock, et al,2000)

Purine and Pyrimidine Nucleotide Biosynthesis:
The most important roles of folic acid derivatives may be synthesis of purine
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and pyrimidine nucleotides. To synthesize the purine ring, 10-formyl-H4PteGlu
will donate one-carbon unit to aminoimidazole-4-carboxamide ribonucleotide
(AICAR)

and

glycinamide

ribonucleotide

(GAR)

respectively,

and

10-formyl-H4PteGlu will become H4PteGlu1.( Mark Lucock, et al, 2000) The
enzymes responsible for this reaction are AICAR transformylase and GAR
transformylase. On the other hand, to synthesize the pyrimidine nucleotides,
deoxyuridylate monophosphate (dUMP) will be methylated by thymidylate
synthase (TS) which is rate limiting enzyme in the elaboration of DNA to form
thymidylate monophosphate (TMP), and 5,10-methylene-H4PteGlu as a donor
will be converted to H2PteGlu in this reaction. (Mark Lucock, et al, 2000)

The Interconversion of Serine and Glycine:
Serine hydroxymethyltransferase (SHMT) is the enzyme responsible for
reversible interconversion of serine and glycine, and this reaction requires
vitamin B6 as a cofactor:
H4PteGlu + serine + NAD+ <---> 5,10-methylene-H4PteGlu + glycine +
H2O.
Actually, 5,10-methylene-H4PteGlu is at the branch point for three important
pathways (Green JM, et al, 1988), because 5,10-methylene-H4PteGlu can be
converted to 5-methyl-H4PteGlu by 5,10MTHFR; and then with the help of
B12-dependent MetSyn, homocysteine (Hcy) can be converted to methionine
while the 5-methyl-H4PteGlu was converted to H4PteGlu (Banerjee RV, et al,
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1990); also with the enzymes of TS, 5,10-methylenetetrahydrofolate
dehydrogenase

and

5,10-methylenetetrahydrofolate

cyclohydrolase,

5,10-methylene-H4PteGlu can be used to synthesize the DNA thymine and
purine, respectively.

The Homocysteine Remethylation Cycle: Folate-Dependent de Novo Methionine
Biosynthesis:
From picture 2, we can see that homocysteine (Hcy) connects two important
pathways and is regulated by several enzymes. One is the biosynthesis of
methionine from Hcy which is activated when the S-adenosylmethionine (SAM)
level drops. The other pathway is the transulphuration from Hcy to cystathionine
which is activated by elevated level of SAM (Selhub J, et al, 1992).
Before Hcy enters the remethylation cycle, 5,10-methylene-H4PteGlu will first
be reduced to 5-methyl-H4PteGlu by 5,10MTHFR, which in vivo is irreversible
(Green JM, et al, 1988). Then while converting 5-methyl-H4PteGlu to the
H4PteGlu by Vitamin B12-dependent methionine synthase (MetSyn) and
methionine synthase reductase (MSR) which reductively activates MetSyn, then
Hcy will be converted to methionine (Banerjee RV, et al, 1990; Leclerc D, et al,
1998). When methionine is activated by ATP, the methionine can be converted
to the methyl donor SAM by the enzyme methionine adenosyltransferase. SAM
is an essential molecule since a variety of important biomolecules such as
adrenalin, phosphatidylcholine, and carnitine are methylated by it and it can
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regulate both remethylation and transsulphuration pathways (Green JM, et al,
1988).

After

the

methylation

process,

SAM

is

converted

to

S-adenosylhomocysteine (SAH), and then SAH will be hydrolyzed back to Hcy
by S-Adenosylhomocysteine hydrolase to recommence a new remethylation
cycle (Finkelstein JD, et al, 1974).
When the Hcy is converted to cystathionine by transsulphuration reaction, the
the thiol group in Hcy will condense with serine by cystathionine β-synthase
in which vitamin B6 works as a cofactor. Once it enters the transsulphuration
pathway, Hcy will no longer serve as a precursor for methionine biosynthesis
and the cystathionine will be further hydrolyzed to cysteine and α-ketobutyrate
by another B6-dependent enzyme, γ-cystathionase.(Mark Lucock, et al, 2000)
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Picture 3: The role of the proteins coded by studied genes in folate
metabolism.(Min shena, et al, 2005)
As we know folate is involved in one-carbon transfer pathways. The folate
influences the thymidine monophosphate (dTMP) and the purine nucleotides
synthesis, consequently affect the DNA synthesis and repair. Through the
one-carbon pathway, the folate level also influences the DNA methylation,
consequently affect the gene expression. The picture 3 illustrate the genes relate
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to folate metabolic pathways and I will explain the function of these genes in the
following content:
Reduced folate carrier ( RFC ) is the primary cellular transport system for the
intake of reduced folates and folic acid antagonists (i.e., antifolates) including
methotrexate (MTX), which functions as a bidirectional anion exchanger, taking
up folate cofactors and exporting various organic anions, including thiamine
pyrophosphate. (Nunez MI, et al, 2012)
Thymidine kinase (TK) is an ATP-thymidine 5'-phosphotransferase which
can be found in most living cells. It is present in two forms in mammalian cells,
TK1 and TK2. (Xu Y, et al, 2012)
Thymidine kinase catalyses the reaction:


Thd + ATP → TMP + ADP



Thd:

deoxythymidine,

ATP:

adenosine

5’-triphosphate,

TMP:

deoxythymidine 5’-phosphate a, ADP: adenosine 5’-diphosphate.
Since thymidine kinases is part of the unique reaction chain to introduce
deoxythymidine into the DNA, it plays important role in the synthesis of DNA
and thereby in cell division. (Xu Y, et al, 2012)
Serine

hydroxymethyltransferase

1

(SHMT1)

is

a

pyridoxal

phosphate-containing enzyme that catalyzes the reversible conversion of serine
and tetrahydrofolate to glycine and 5,10-methylene-tetrahydrofolate:
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H4PteGlu + serine + NAD+ <---> 5,10-methylene-H4PteGlu + glycine +
H2O.
And then the 5,10-methylenetetrahydrofolate from this reaction will serve as a
key component for synthesis of methionine, thymidylate, and purines in the
cytoplasm. (Weiner AS, et al, 2012)
Serine hydroxymethyltransferase 2 (SHMT2) is the mitochondrial form of a
pyridoxal phosphate-dependent enzyme that catalyzes the reversible reaction of
serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate in
mitochondrial. The SHMT2 actually is primarily responsible for glycine
synthesis which has been suggested to be the primary source of intracellular
glycine. (Hebbring SJ, et al, 2102)
Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
(GGH) is the gene that codes for an enzyme that catalyzes the hydrolysis of
folylpoly-gamma-glutamates and antifolylpoly-gamma-glutamates to give
5-methyl-tetrahydrofolate by the removal of gamma-linked polyglutamates and
glutamate.( Silva IH, et al,2013)
Folylpolyglutamate synthase (FPGS) is the gene that encodes the enzyme that
catalyzes the ATP-dependent addition of glutamate moieties to folate and
convert them to polyglutamate derivatives, in which the tetrahydrofolate is the
enzyme's major substrate.
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ATP + tetrahydropteroyl-(gamma-Glu)(n) + L-glutamate = ADP +
phosphate + tetrahydropteroyl-(gamma-Glu)(n+1).
So that, this enzyme has been playing an important role in retaining both
cytosolic and mitochondrial folylpolyglutamate in appropriate concentrations
which is essential for the survival of proliferating cells. (Christoph DC, et al,
2012)
Thymidylate synthase (TYMS) is the gene that encodes the enzyme that
catalyzes the conversion of deoxyuridylate to deoxythymidylate by methylation
using 5,10-methylenetetrahydrofolate (methylene-THF) as a one-carbon unit
cofactor. This enzyme establishes and maintains the dTMP (thymidine-5-prime
monophosphate)

pool

which

is

critical

for

DNA

replication

and

repair.( Christoph DC, et al, 2012)
Dihydrofolate reductase (DHFR) is the gene that encodes the enzyme that
converts dihydrofolate into tetrahydrofolate which is an important substrates
required for the de novo synthesis of purines, thymidylic acid, and certain amino
acids. (Milic V, et al, 2012)
Methylenetetrahydrofolate reductase (NAD(P)H) (MTHFR) is the protein
encoded

by

this

gene

5,10-methylenetetrahydrofolate

that
to

catalyzes

the

conversion

5-methyltetrahydrofolate

which

of
is

a

one-carbon unit co-substrate for homocysteine remethylation to methionine.
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This enzyme is regulated by the concentration of SAM and dihydrofolate, when
the

level

of

SAM

increased

,

the

activity

of

MTHFR

will

be

inhibited.( Trifonova EA, et al, 2012)
Methylenetetrahydrofolate dehydrogenase 1 (NADP+ dependent) (MTHFD1)
is the gene that encodes an enzyme that has three distinct enzymatic activities:
The

5,10-methylenetetrahydrofolate

5,10-methylenetetrahydrofolate

to

convert

5,10-methenyltetrahydrofolate;

5,10-methenyltetrahydrofolate
5,10-methenyltetrahydrofolate

dehydrogenase

cyclohydrolase
to

the

convert

10-formyltetrahydrofolate;

and

the

10-formyltetrahydrofolate synthetase convert 10-formyltetrahydrofolate to
tetrahydrofolate.

This

enzyme

can

be

used

to

recycle

the

5,10-methylenetetrahydrofolate back to tetrahydrofolate which is an essential
substrates for de novo synthesis of methionine, thymidylate, and purine.
(Zampieri BL, et al, 2012)
Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is the gene that
encodes

a

mitochondrial

methylenetetrahydrofolate

bifunctional

dehydrogenase

enzyme
and

which

has

both

methenyltetrahydrofolate

cyclohydrolase activities. The enzyme functions as a homodimer and requires
magnesium and inorganic phosphate to works as cofactor, which will lead to the
formation of enzyme-magnesium complex allowing the binding of NAD+.
(Zampieri BL, et al, 2012)

12

5-methyltetrahydrofolate-homocysteine

methyltransferase

(MTR)

(also

known as cobalamin-dependent methionine synthase) is the gene encodes the
enzyme that catalyzes the conversion of homocysteine to methionine with
vitamin B12 work as cofactor and also converted 5-methyltetrahydrofolate to
tetrahydrofolate . (Weiner AS, et al, 2012)
5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR)
is the protein encoded by this gene. As we know methionine is an essential
amino acid in protein synthesis and one-carbon metabolism, and it is synthesized
by the enzyme methionine synthase which might eventually become inactive
since the vitamin B12 cofactor will oxidize it during the synthesis process. The
MTRR can regenerate a functional methionine synthase via reductive
methylation. (Zhou D, et al, 2012)
Cystathionine-beta-synthase (CBS) is the gene that encodes the enzyme that
catalyzes the conversion of homocysteine to cystathionine with serine as
co-substrate and it is the first step in the transsulfuration pathway. This enzyme
will be activated by elevated level of SAM and uses vitamin B6 as a cofactor.
(Pey AL, et al, 2013)
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Purpose of this study:
This subject is significant and important for thesis study because it could tell
us how the cells will regulate their folate metabolism enzymes when they are
under the stress of folate depletion. Our hypothesis is the MEF cells will
regulate their folate metabolism enzymes in different ways compared with
BNL CL.2 cells when they suffer folate depletion.
In order to test our hypothesis we will inspect the changes in gene expression
of 15 genes which are related to the folate metabolism in two different cell lines.
One is MEF cell line and the other one is BNL-C2 cell line. These two cell lines
will be both raise in full folate medium and folate depletion medium. And then
we will isolate the RNA from these two cell lines and make the cDNA from it to
run the real-time PCR to figure out the difference of gene expression change
level between the MEF and BNL-CL2 cell lines when they suffer the folate
depletion condition.
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MATERIALS AND METHODS:
Tissue Cultures:
Transformed SV40 T-antigen mouse embryonic fibroblasts (MEFs) were
derived from the embryos (ung+/+) of the ung moused developed by Endres et
al. [Endres M, 2004]. BNL CL. 2 were normal liver cells derived from BALB/c
mice. These cells were grown in either folate added standard DMEM (GIBCO
BRL, Grand Island, NY, USA) containing 4.5g/L glucose, 4mg/L folic acid,
glutamax, glutamine, 10% dialyzed fetal bovine serum or customized folate-free
DMEM (GIBCO BRL) media supplemented with 10% dialyzed fetal bovine
serum, glutamax and glutamine. Each of the growth media was supplemented
with 1% penicillin-streptomycin and both MEF and BNLCL.2 cells were
incubated at 37°C in 10% C02. For getting the folate depleted cells, at first,
folate-free media will be supplied with low amount of thymidine and adenosine
so that the cells can survive. And then, the percentage of T/A will be reduce
stepwise over time, 1X being the starting concentration. The MEF cells and
BNL CL2 cells were both passaged three times for each T/A concentration until
0% T/A was achieved. Before each passage, the cells were grown until they
became 75% confluent.
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Harvesting Cells:
The flasks of cells were first visualized under the microscope to determine if
the cells were 75% confluent. The old media from the cells was removed and the
flasks were washed with 5 ml of pre-warmed 1X PBS-EDTA. Once the 1X
PBS-EDTA was removed, 2 ml of trypsin was added. The flasks were then
incubated for approximately 2-3 minutes at 37°C in order to detach the cells
from the bottom of the flask. The cells were again viewed under the microscope
to ensure that the cells were lifted off the flask. To stop the trypsin from working,
3 ml of complete growth media was added. Using a serological pipette, the cells
were pipette up and down several times for the cells to separate from each other.
The cells along with the added complete media were transferred into a 15 ml
conical tube for washing. The cells were centrifuged for 5 minutes at 1300 rpm
at 4°C. The media was carefully removed without disturbing the white visible
pellet on the bottom of the conical tube and 5 ml of 1X PBS was added to the
pellet. The cells were again centrifuged at 1300 rpm for 5 minutes at 4°C and the
1X PBS was carefully removed without removing the pellet. Then we will add
the 1ml Isol-RNA Lysis Reagent to the pellet and mix well to isolate the RNA in
next step.
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Doubling Times:

Picture 4: The calculation of doubling time.
The MEF cells and BNL CL 2 cells were examined daily under a light
microscope, observing the morphology, density of the cells, and color of the
media. Once the cells became 75% confluent, the 10 mm petri dishes containing
the cells were carefully removed from the incubator. Then ,we will harvest the
cells as above shows. Once a single cell suspension was achieved, the cells were
transferred into a 15-ml conical tube. Trypan blue (10μl), which is rejected by
live cells but accumulates in dead cells, was transferred into a 1.5 ml eppendorf
tube along with 10μl of cells and counted in the TC 10 Automated Cell counter.
The total number of cells/ml was then calculated as picture 4 shows and used to
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determine the amount of cells to plate for the next passage. And we can obtain
the doubling time of MEF cells and BNL CL2 cells easily by the equation:

Td is the doubling time, t1 is the time we passage the cells, t2 is the time we
harvest the cells, q1 is the number of cells we plated at first, q2 is the total
number of cells after we harvested.
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RNA Isolation:
Once the cell were harvest, The whole RNA will be isolated using Isol-RNA
Lysis Reagent (5 Prime Inc, Gaithersburg, MD). First, we will let samples
incubate in Isol-RNA Lysis Reagent (5 Prime Inc, Gaithersburg, MD) for 5
minutes at room temperature. And then spinning them at 12,000g for 10 minutes
at 4°C, so that DNA will pellet down and we can collect supernatant. After that,
to each sample, we add 0.2 ml of chloroform for every 1 ml of Isol-RNA Lysis
Reagent (5 Prime Inc, Gaithersburg, MD) used and shake vigorously for 15
seconds and incubate at room temperature for 2-3 minutes. After incubation ,we
centrifuge samples at 12,000 x g for 10 minutes at 4°C. The 4 degree spins are
essential for proper phase separation. And then we transfer the aqueous phase to
a fresh tube. The aqueous phase is the colorless upper phase that corresponds to
~60% of the volume of Isol-RNA Lysis Reagent (5 Prime Inc, Gaithersburg,
MD) used. Then we add 0.5 ml isoproponal into samples and mix by pipetting.
Also, we incubate them at room temperature for 10 minutes and centrifuge for
10 minutes at 12,000 x g at 4°C. After that we remove the supernatant from each
sample. A pellet should be observed at the bottom of the tube. Then we wash the
Pellet with 1 ml of 75% ethanol for every 1 ml of Isol-RNA Lysis Reagent (5
Prime Inc, Gaithersburg, MD) used and mix samples by flicking and inverting
the tubes or by vortexing. The pellet should come loose from the bottom of the
tube, but remain intact. And then we centrifuge at 7500 x g for 5 minutes at 4°C.
After that, we need to remove all of the ethanol from each tube, but not to
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disrupt the pellet and redissolve the pellet by adding 30 ul of RNase free water.
If the pellet is not dissolved, then we incubate them at 55-60°C for ~10 minutes
with the interval of every 2 minutes. Finally , we need to quantify RNA samples
using Nanodrop, so that we can made the cDNA in next step.
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cDNA Synthesis:
After the isolation of whole RNA from cells, we can synthesis cDNA from
the RNA we isolated. First , we need to Prepare the reverse transcription
reaction mix by combining the following components of the RT-PCR kit (Perkin
Elmer, Waltham, MA) in a sterile 1.5 ml microcentrifuge tube on ice.
Master Mix
 Nuclease-free water (Perkin Elmer, Waltham, MA)

5 µl

 5x Reaction Buffer (Perkin Elmer, Waltham, MA)

4µl

 MgCl2 (Perkin Elmer, Waltham, MA)

4µl

 dNTP

1µ

(Perkin Elmer, Waltham, MA)

 Reverse Transcriptase (Perkin Elmer, Waltham, MA)

1µl

We need to prepare sufficient mix to allow 15 µl for each cDNA synthesis
reaction to be performed and vortex them gently to mix and keep them on ice
prior to dispensing into the reaction tubes. After that , we aliquot 15 µl of the
reverse transcription reaction mix to each reaction tube on ice and be careful to
prevent cross-contamination. Then , we thaw the experiment RNA and return
any unused portion to the freezer as soon as aliquots are taken. On ice, we
combine the experimental RNA (500ng-1000ng) and the cDNA random primer
in nuclease-free water for final volume of 5 µl per RT reaction.
 Reaction primer = 1 µl
 RNA

= 1-3 µl (depending on concentration)
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 dH2O

= ____ (certain volume to make total = 5 µl)

 Total

= 5 µl

Then ,we close each tube of RNA tightly and place the tubes into a preheated
70°C heat block for 5 min. After that , we immediately chill the samples on ice
for 5 min and then spin each tube for 10 seconds in microcentrifuge to collect
the condensate. Then we add 5 µl of RNA and primer mix to the reaction tubes
containing RTase reaction mix left on ice in early step. we cap the tubes and
centrifuge for 1 min to mix the samples and then place the reaction tubes in the
thermocycler (Eppendorf North America, NY) and set parameters:
 5 min @ 25°C
 60 min @ 42°C
 15 min @ 70°C
 Hold @ 4°C


Can store at -20°C

And then, we purify the cDNA samples with QIAquick PCR Purification Kit
(Qiagen, Valencia, CA) and quantify the cDNA using NANO-DROP
(Eppendorf North America, NY)
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Gene Cloning:
Once we synthesis the cDNA, we can amplify the gene fragments we want
from the cDNA samples with specific design primers. And then we will insert
the gene fragment we targeted into a well designed plasmid called pCRII-topo
(Life Technologies, Grand Island, NY) that has a single 3' overhanging
nucleotide (a thymidine).
...GAATTCGCCCTT

AGGGCGAATTC...

...CTTAAGCGGGA

TTCCCGGTTAAG...

This vector cannot easily reclose since the 3' overhanging ends are
incompatible (both being T bases) to each other. On the other hand, it is perfect
at accepting PCR products made with Taq polymerase (Life Technologies,
Grand Island, NY). Since Taq polymerase (Life Technologies, Grand Island, NY)
has a limited "terminal transferase" activity which can add a single 3'
overhanging adenosine to its products of synthesis:
NNNNNN...NNNNNNA
ANNNNNN...NNNNNN
And then we will transform the recombinant plasmids to the competent cells
and spread them on the LB agar plates with X-gal and Ampicillin on it. Since
the plasmid contains the antibiotic gene on it, only the cell harbor the plasmids
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can survive on the ampicillin contained agar plates. Also, since we using the
blue-white screening system to distinguish the colonies (clones) of transgenic
cells from those that contain the parental vector, we will select the white
colonies to raise them in LB broth overnight and then isolate the plasmids for
standard curves later.
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Real Time RT‐PCR:
Once total RNA was isolated from the MEF and BNL CL.2 cells, 2μg of
isolated RNA was used to synthesize cDNA using random hexamer primers and
an RT-PCR kit (Perkin Elmer, Waltham, MA). The newly synthesized cDNA
was then purified using the QIAquick PCR Purification Kit (Qiagen, Valencia,
CA). A LightCycler real time PCR machine (Roche, Indianapolis, IN) was used
to quantify the transcripts. Each PCR reaction consisted of 2μL of purified
cDNA, 4mM MgCl2, 0.5μM each of sense and antisense primers, and 2μL of
FastStart DNA master SYBR Green I enzyme-SYBR reaction mix (Roche). The
parameters for all of the amplifications are detailed in Table 1. All the
transcripts were normalized to the housekeeping gene, RPL-4.
Table 1 Real Time PCR parameters for all amplifications.
Duration

Temperature

Initial denaturing step

10 min

99°C

Denature

10 sec

96°C

Annealing

10 sec

62°C

Extension

5 sec

72°C

Melting

40°C -99°C

Table 2: Primer sequences in quantitative real time RT-PCR
Gene

Sense-primer 5′-3′

Anti-sense primer 5′-3′

RFC

GTGGAGTGTCATCTTGGCCCG

CGTTCCAGGAGGAAGGGTGTG
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TK

AAGTGCCTGGTCATCAAGTATG

GCTGCCACAATTACTGTCTTGC

SHMT1

GGGTCGGATTAGAGCTGATTG

GGTCCCGCCATAATACCTTTG

SHMT2

TGGCAAGAGATACTACGGAGG

GCAGGTCCAACCCCATGAT

GGH

CCATAAGGCCCGATCTTAGTGA

TCTGTTAGGTTAGCACCTCCTC

FPGS

ACACCCTGCAAACCAATGC

CTCCGTGCCAGGTACATCTC

TYMS

AAGGGTGTTTTGGAGGAGTTG

TTGGCATCCCAGATTCTCACT

DHFR

CGCTCAGGAACGAGTTCAAGT

TGCCAATTCCGGTTGTTCAATA

MTHFR

GGCAGCGAGAGTTCCAAGG

CAGGGAGAACCACTTGTCACC

MTHFD1

GGGAATCCTGAACGGGAAACT

TGAGTGGCTTTGATCCCAATC

MTHFD2

AGTGCGAAATGAAGCCGTTG

GACTGGCGGGATTGTCACC

MTR

ATCCAGCGGTACAAACTAAGTG

CATCCGGTAGGCCAAGTGTTC

MTRR

GGACAGGCAAAGGCCATAG

ACCCGTGGTAGATACAACCAT

CBS

CCAGGCACCTGTGGTCAAC

GGTCTCGTGATTGGATCTGCT
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Folate Microbiology Assay:
Folate was measured from the MEF and BNL CL.2 cells using the folate
microbiological assay as described by Home et al [Home DW, 1988]. This
widely used microbiological assay measures folic acid derivatives in serum as
well as other biological samples [Home DW, 1988]. The folinic acid (calcium
salt) [(6-ambo)-5-HCO-H4PteGlu] was prepared in water at a concentration of 6
mM (6×106 fmol/μ) and diluted to 6×103 fmol/μl, which was then diluted to 60
fmol/ μl and eventually to a final dilution of 2b fmol/μl (working solution). The
single strength folic acid casei medium was prepared by dissolving 9.4 gram of
the powder folic acid casei medium and 50 mg of sodium ascorbate (Vitamin C)
into 100 ml of diH2O. The mixture was then filtered through a 0.22-μm sterile
syringe filter. The working buffer was prepared by dissolving 3.2 gram of
sodium ascorbate into 19 ml of diH2O and adding 1 ml potassium phosphate
buffer (1mol/l, pH 6.1). The mixture was then sterilized through a 0.22-μm
sterile syringe filter. Lastly, the L. casei inoculum was prepared. One vial of
lyophilized Lactobacillus casei, stored at -80°C when first received, was
suspended in 1 ml of the medium to grow overnight at 37°C. From this
inoculum, 0.25 ml was added to the remaining 199 mL of medium and
incubated for approximately 18 hours at 35°C. The mixture was then cooled
down in an ice bath. An equal volume of cold (4°C) sterile glycerol (800ml/L)
was added to the mixture. From the mixture, 2ml aliquots were prepared and
stored at -80°C. Once the L. casei inoculum was incubated overnight at 37°C,
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the OD was measured and diluted to an OD value of 0.5 (the standard OD value
of the L. casei inoculum). The microtiter plate was then set up as shown in Table
3. A multiple pipette was used to add the working buffer mixture (8 μl/sample)
and media (150 μl/sample) along with either autoclaved or sterile water. As
shown in Table 4, 2 fmol/ μl of folate with the corresponding volume was added
to each designated well on the plate. Due to folate being light sensitive, the
lights were turned off during the procedures of this assay. Using a multiple
pipette, 20 μl of Lactobacillus casei (OD=0.05) was added to the standards and
samples for the exception of one blank. Autoclaved or sterile water was added
around the well of the microtiter plate to create enough humidity whereas
parafilm was used to cover the plate in order to keep the humidity within the
microtiter plate. The plate was also covered with oil film to prevent the
degrading of folate from light. The plate was incubated overnight at 37°C for
approximately 18 hours. Before the plate was read at an absorbance of
approximately 570-635 using a Dynatech Model MR600 reader, the pellet of the
bacteria was resuspended using a pipette.
Table 3: Folate assay microtiter plate setup
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Table 4: Folate assay reaction mixture
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RESULT & DISCUSSION:

TAg92 folate level
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10
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Figure 1: Absence of Folate in media induces folate depletion in MEF cells. (*p value <
0.01.) Folate levels in MEFS cells was measured using the microbiological assay as described
in methods. The level of folate is very low ( near 0 ) when they are grown under folate
depletion condition which resulted in almost 100% reduction in folate level.

BNLC2 folate level
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Figure 2: Absence of Folate in media induces folate depletion in BNL CL.2 cells. (*p
value < 0.01.) Folate levels in BNL CL.2 cells was measured using the microbiological assay
as described in methods. The level of folate is very low ( near 10 ) when they under the folate
depletion condition which resulted in greater than 90% reduction in folate level.
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Figure 3: Absence of Folate in media induces CBS/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. CBS transcript levels were determined by real time RT-PCR analysis and normalized
to RPL4. Data are presented relative to expression in folate added group. Compared with full
folate added cell lines, the CBS expression was elevated more than 2 fold in MEF cell lines
under folate depletion condition.
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Figure 4: Absence of Folate in media induces CBS/RPL4 expression in BNL CL.2 cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. CBS transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the CBS expression was elevated around 2 fold in
BNL CL.2 cell lines under folate depletion condition.
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Figure 5: Absence of Folate in media induces GGH/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. GGH transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the GGH expression was elevated more than 2 fold
in MEF cell lines under folate depletion condition.
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Figure 6: Absence of Folate in media induces GGH/RPL4 expression in BNL CL.2 cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. GGH transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the GGH expression was elevated more than 2 fold
in BNL CL.2 cell lines under folate depletion condition.
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Figure 7: Absence of Folate in media induces MTR/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. MTR transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the MTR expression was elevated 2 fold in MEF
cell lines under folate depletion condition.

BNL CL2 MTR/RPL4 Expression
MTR/RPL4 Expression

3.00E+00

*

2.50E+00
2.00E+00

p < 0.01

1.50E+00
1.00E+00
5.00E-01
0.00E+00
BNL-c2 +folate

BNL-c2 0% Ad/thy

Figure 8: Absence of Folate in media induces MTR/RPL4 expression in BNL CL.2 cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. MTR transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added
group.Compared with full folate added cell lines, the MTR expression was elevated around 2
fold in BNL-CL.2 cell lines under folate depletion condition.
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Figure 9: Absence of Folate in media induces RFC/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. RFC transcript levels were determined by real time RT-PCR analysis and normalized
to RPL4. Data are presented relative to expression in folate added group. Compared with full
folate added cell line, the RFC expression were elevated in MEF cell lines under folate
depletion condition.
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Figure 10: Absence of Folate in media depress RFC/RPL4 expression in BNL CL.2 cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. RFC transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added
group.Compared with full folate added cell line, the RFC expression were depressed in BNL
CL.2 cell lines under folate depletion condition.
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Figure 11: Absence of Folate in media induces TYMS/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. TYMS transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the TYMS expression was elevated more than 2
fold in MEF cell lines under folate depletion condition.
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Figure 12: Absence of Folate in media induces TYMS/RPL4 expression in BNL CL.2
cells. (*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. TYMS transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the TYMS expression was elevated more than 2
fold in BNL CL.2 cell lines under folate depletion condition.
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Figure 13: Absence of Folate in media induces FPGS/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. FPGS transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell line, the FPGS expression was elevated in MEF cell
lines under folate depletion condition.
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Figure 14: Absence of Folate in media did not influence FPGS/RPL4 expression in BNL
CL.2 cells. cDNAs were prepared from RNA isolated from BNL CL2 cells as described in
method. FPGS transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell line, the FPGS expression did not significantly change
much in BNL CL.2 cell lines under folate depletion condition.
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Figure 15: Absence of Folate in media induces MTHFD1/RPL4 expression in MEF cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. MTHFD1 transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell line, the MTHFD1 expression was elevated in MEF cell
lines under folate depletion condition.
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Figure 16: Absence of Folate in media did not influence MTHFD1/RPL4 expression in
BNL CL.2 cells. cDNAs were prepared from RNA isolated from BNL CL2 cells as described
in method. MTHFD1 transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell line, the MTHFD1 expression did not change much in
BNL CL.2 cell lines under folate depletion condition.
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Figure 17: Absence of Folate in media depress MTHFD2/RPL4 expression in MEF cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. MTHFD2 transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the MTHFD2 expression was depressed in MEF
cell lines under folate depletion condition.
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Figure 18: Absence of Folate in media depress MTHFD2/RPL4 expression in BNL CL.2
cells. (*p value < 0.05.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. MTHFD2 transcript levels were determined by real time RT-PCR
analysis and normalized to RPL4. Data are presented relative to expression in folate added
group. Compared with full folate added cell lines, the MTHFD2 expression was depressed in
BNL CL.2 cell lines under folate depletion condition.
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Figure 19: Absence of Folate in media induces MTHFR/RPL4 expression in MEF cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. MTHFR transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the MTHFR expression was elevated 2 fold in
MEF cell lines under folate depletion condition.
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Figure 20: Absence of Folate in media induces MTHFR/RPL4 expression in BNL CL.2
cells. (*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. MTHFR transcript levels were determined by real time RT-PCR
analysis and normalized to RPL4. Data are presented relative to expression in folate added
group. Compared with full folate added cell lines, the MTHFR expression was elevated in
BNL-CL.2 cell lines under folate depletion condition.
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Figure 21: Absence of Folate in media induces MTRR/RPL4 expression in MEF cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. MTRR transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the MTRR expression was elevated in MEF cell
lines under folate depletion condition.
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Figure 22: Absence of Folate in media induces MTRR/RPL4 expression in BNL CL.2
cells. (*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. MTRR transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the MTRR expression was elevated in BNL CL.2
cell lines under folate depletion condition.
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Figure 23: Absence of Folate in media induces DHFR/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. DHFR transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the DHFR expression was elevated more than 2
fold in MEF cell lines under folate depletion condition.
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Figure 24: Absence of Folate in media induces DHFR/RPL4 expression in BNL CL.2
cells. (*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. DHFR transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the DHFR expression was elevated more than 2
fold in BNL CL.2 cell lines under folate depletion condition.

41

SHMT1/RPL4 Expression

MEF SHMT1/RPL4 Expression
2.00E+00
1.80E+00
1.60E+00
1.40E+00
1.20E+00
1.00E+00
8.00E-01
6.00E-01
4.00E-01
2.00E-01
0.00E+00

*

P<0.01

MEF +folate

MEF 0% Ad/thy

Figure 25: Absence of Folate in media induces SHMT1/RPL4 expression in MEF cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. SHMT1 transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the SHMT1 expression was elevated almost 2 fold
in MEF cell lines under folate depletion condition.
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Figure 26: Absence of Folate in media induces SHMT1/RPL4 expression in BNL CL.2
cells. (*p value < 0.05.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. SHMT1 transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the SHMT1 expression was elevated in BNLCL.2 cell lines under folate depletion condition.
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Figure 27: Absence of Folate in media depress SHMT2/RPL4 expression in MEF cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. SHMT2 transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the SHMT2 expression was depressed in MEF cell
lines under folate depletion condition.
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Figure 28: Absence of Folate in media depress SHMT2/RPL4 expression in BNL CL.2
cells. (*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. SHMT2 transcript levels were determined by real time RT-PCR analysis
and normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the SHMT2 expression was depressed in BNL
CL.2 cell lines under folate depletion condition.
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Figure 29: Absence of Folate in media induces TK/RPL4 expression in MEF cells. (*p
value < 0.01.) cDNAs were prepared from RNA isolated from MEF cells as described in
method. TK transcript levels were determined by real time RT-PCR analysis and normalized
to RPL4. Data are presented relative to expression in folate added group. Compared with full
folate added cell lines, the TK expression was elevated more than 2 fold in MEF cell lines
under folate depletion condition.
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Figure 30: Absence of Folate in media induces TK/RPL4 expression in BNL CL.2 cells.
(*p value < 0.01.) cDNAs were prepared from RNA isolated from BNL CL2 cells as
described in method. TK transcript levels were determined by real time RT-PCR analysis and
normalized to RPL4. Data are presented relative to expression in folate added group.
Compared with full folate added cell lines, the TK expression was elevated in BNL CL.2 cell
lines under folate depletion condition.
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Figure 31: Doubling time of MEF cells and BNL CL2 cells in full folate media. (*p value
< 0.05.) MEF cells and BNL CL2 cells are raised in full folate media. After we harvested the
cell ,we will calculate the doubling time of the two cell line respectively as the method
described before. Compared with MEF cell line, the doubling time of BNL CL2 cell line was
increased nearly 2 fold.
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Figure 32: Doubling time of MEF cells and BNL CL2 cells in folate depleted media. (*p
value < 0.05.)
MEF cells and BNL CL2 cells are raised in folate depleted media. After we harvested the
cell ,we will calculate the doubling time of the two cell line respectively as the method
described before. Compared with MEF cell line, the doubling time of BNL CL2 cell line was
increased more than 2 fold.
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From Figures 1and 2, we can be sure that the MEF cell line and BNL CL.2
cell line we used are truly folate depleted. This allows us to directly connect the
gene expression results to folate status.
From the figure 3 to figure 30, we see that with the exception of RFC, FPGS,
SHMT1 and MTHFD1, most of the folate metabolizing genes (TK, SHMT2,
GGH, TYMS, DHFR, MTHFD2, MTHFR, MTR, MTRR and CBS) have the
similar expression patterns in response to folate depletion condition. Such as the
gene expressions of CBS, GGH, MTR, TYMS, MTHFR, MTRR, DHFR, and
TK are all significantly elevated when the two cell lines suffered the folate
depletion condition; while the gene expressions of MTHFD2 and SHMT2 are
significantly depresses when they suffered the folate depletion.
But since our hypothesis is the MEF cells will regulate their folate metabolism
enzymes in different ways compared with BNL CL.2 cells when they suffer
folate depletion, we will focus on explaining the results that shows different
change level between the two cell lines.
The first one that shows different change level is the RFC gene (figure 9 and
figure 10), the RFC expression was significantly elevated in MEF cell lines
while the RFC expression was depressed in BNL CL2 cell line. As we have
talked before, RFC is the primary cellular transport system for the intake of
reduced folates and folic acid antagonists (i.e., antifolates) including
methotrexate (MTX), which functions as a bidirectional anion exchanger, taking
up folate cofactors and exporting various organic anions, including thiamine
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pyrophosphate (Nunez MI, et al, 2012). So, the RFC expression was elevated in
MEF cell line might be due to the cell needing to take up more folate from the
environment to fulfill their needs of replication and growth. But the RFC
expression was depressed in BNL CL2 cell line might be due to the cell already
adapt the environment with depleted folate, they don't need so much transporters
to intake the folate from outside to save some energy. And the BNL CL2 cells
are trying to maintain the homeostasis of folate concentration inside the cell by
growing slowly and less replication.
The second one that shows different change level is the FPGS gene (figure 13
and figure 14), the FPGS expression was significantly elevated in MEF cell lines
while the RFC expression didn't has much change in BNL CL2 cell line. As we
have known that FPGS was the gene encodes the enzyme that catalyzes the
ATP-dependent addition of glutamate moieties to folate and convert them to
polyglutamate derivatives, in which the tetrahydrofolate is the enzyme's major
substrate.
ATP + tetrahydropteroyl-(gamma-Glu)(n) + L-glutamate = ADP +
phosphate + tetrahydropteroyl-(gamma-Glu)(n+1).
So that, this enzyme has been playing an important role in retaining both
cytosolic and mitochondrial folylpolyglutamate in a appropriate concentrations
which is essential for the survival of proliferating cells(Christoph DC, et al,
2012). So, the FPGS expression was significantly elevated in MEF cell line
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might due to the cell try to maintain the concentration of folate and folate
derivatives inside the cytosol or mitochondria, because the MEF cells are
replicate really fast and frequently, they need lots of folate derivatives to
synthesize the thymine and purine which make the DNA. But the FPGS
expression didn't change much in BNL CL2 cell line might be due to the role of
liver as the central organ to maintain folate homeostasis, they will release the
folylpolyglutamate to the plasma and let them circulate to other organs where
needs the folate derivatives. Since the liver cells don't need much folate
derivatives to support their replication and growth, they may not need to urge
themselves to maintain the concentration of folate and folate derivatives inside
the cytosol or mitochondria by elevating the FPGS expression even under the
folate depletion condition.
The third gene differentially regulated in the two cell lines is MTHFD1
(figure 15 and figure 16). MTHFD1 expression was significantly elevated in
MEF cell lines while the MTHFD1 expression didn't change in BNL CL2 cell
line. As we talked before, MTHFD1 encodes an enzyme that has three distinct
enzymatic activities: The

5,10-methylenetetrahydrofolate dehydrogenase

convert 5,10-methylenetetrahydrofolate to 5,10-methenyltetrahydrofolate; the
5,10-methenyltetrahydrofolate
5,10-methenyltetrahydrofolate

cyclohydrolase
to

convert

10-formyltetrahydrofolate;

and

the

10-formyltetrahydrofolate synthetase convert 10-formyltetrahydrofolate to
tetrahydrofolate.

This

enzyme

can

be

used

to

recycle

the
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5,10-methylenetetrahydrofolate back to tetrahydrofolate which is an essential
substrates for de novo synthesis of methionine, thymidylate, and purine
(Zampieri BL, et al, 2012). The reason why the MTHFD1 expression was
significantly increased in MEF cell line might be due to MEF cells are growing
faster and replicating themselves more frequently than BNL-CL2 cells. So, the
MEF cells will need more tetrahydrofolate for the synthesis of methionine,
thymidylate, and purine to make the DNA. But the BNL-CL2 grows more
slowly, so that they might not need to elevate the MTHFD1 expression to get the
tetrahydrofolate.
The fourth gene differentially regulated in the two cell lines is SHMT1 (figure
25 and figure 26). In MEF cell lines, SHMT1 expression was significantly
elevated around 2 fold compared with full folate cells; while in the BNL CL2
cell line, SHMT1 expression just increase slightly. As we introduced before,
SHMT1 is a pyridoxal phosphate-containing enzyme that catalyzes the
reversible conversion of serine and tetrahydrofolate to glycine and
5,10-methylene-tetrahydrofolate:
H4PteGlu + serine + NAD+ <---> 5,10-methylene-H4PteGlu + glycine +
H2O.
And then the 5,10-methylenetetrahydrofolate from this reaction will serve as a
key component for synthesis of methionine, thymidylate, and purines in the
cytoplasm. (Weiner AS, et al, 2012) The reason why the SHMT1 expression was
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significantly increased in MEF cell line might still be due to MEF cells are
growing faster and replicating themselves more frequently than BNL-CL2 cells.
And since the 5,10-methylene-tetrahydrofolate is at the branch point of three
important pathways, which leading to the synthesis of methionine, thymidylate,
and purine, the MEF cells will need more of 5,10-methylene-tetrahydrofolate for
DNA synthesis. But the BNL-CL2 grows more slowly, so that they might not
need to elevate the SHMT1 expression as much as MEF cells did.
Also, from figures 31and 32, we can be sure that MEF cells are growing much
faster than BNL CL2 cells no matter in full folate media or in folate depleted
media, which match what we explained before. So, we can draw a conclusion
that at least the rapidly growing cells such as MEF cells need more
5,10-methylene-tetrahydrofolate and tetrahydrofolate inside the cell for DNA
synthesis or cell growth could be one of the reasons to explain why the RFC,
FPGS, SHMT1 and MTHFD1gene are differentially regulated in the two cell
lines when they both under folate depletion condition.

50

REFERENCES
1. Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase,
FASEB J 4:1450–1459, 1990.
2. Butterworth CE, Santini R, Frohmeyer WB. The pteroylglutamate
components of American diets as determined by chromatographic fractionation.
J Clin Invest 42:1929– 1939, 1963.
3. Christoph DC, et al. Folylpoly-glutamate synthetase expression is associated
with tumor response and outcome from pemetrexed-based chemotherapy in
malignant pleural mesothelioma. J Thorac Oncol, 2012 Sep. PMID 22895141.
4. Donaldson KO, Keresztesy JC. Naturally occuring forms of folic acid. iii.
Characterisation and properties of 5-methyldihydrofolate, an oxidation product
of 5-methyltetrahydrofolic acid. J Biol Chem 237:3815–3819, 1962.
5. Endres M, Biniszkiewicz D, Sobol RW, Harms C, Ahmadi M, Lipski A,
Katchanov J, Mergenthaler P, Dirnagl U, Wilson SH, et al: Increased
postischemic brain injury in mice deficient in uracil-DNA glycosylase. J Clin
Invest 2004, 113:1711-1721.
6. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1:228–
237, 1990; Finkelstein, JD. Methionine metabolism in mammals: The
biochemical basis for homocystinuria. Metabolism 23:387–398, 1974.
7. Green JM, Mackenzie RE, Matthews RG. Substrate flux through
methylenetetrahydrofolate dehydrogenase: Predicted effects of the concentration

51

of methylenetetrahydrofolate on its partitioning into pathways leading to
nucleotide biosynthesis or methionine regeneration, Biochemistry 27:8014–8022,
1988.
8. Green JM, Ballou JP, Matthews RG. Examination of therole of
methylenetetrahydrofolate reductase in incorporation of methyltetrahydrofolate
into cellular metabolism. FASEB J 2:42–47, 1988.
9. Hebbring SJ, et al. Serine hydroxymethyltransferase 1 and 2: gene sequence
variation and functional genomic characterization. J Neurochem, 2012 Mar.
PMID 22220685.
10. Home DW, Patterson D: Lactobacillucsasei Microbiological Assay of Folic
Acid Derivatives in 96-Well Microtiter Plate. Clinical Chemistry 1988,
34:11-2357.
11. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH,
Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA. Cloning and mapping of
a cDNA for methionine synthase reductase, a flavoprotein defective in patients
with homocystinuria. Proc Natl Acad Sci 95:3059–3064, 1998.
12. Mark Lucock. Folic Acid: Nutritional Biochemistry, Molecular Biology,
and Role in Disease Processes,2000
13. Min Shena, Nathaniel Rothmana, Sonja I. Berndta, Xingzhou Heb,
Meredith Yeagerc, Robert Welchc, Stephen Chanockc, Neil Caporasoa, Qing
Lana. Polymorphisms in folate metabolic genes and lung cancer risk in Xuan
Wei, China,2005.

52

14. Milic V, et al. Association of dihydrofolate reductase (DHFR) -317AA
genotype with poor response to methotrexate in patients with rheumatoid
arthritis. Clin Exp Rheumatol, 2012 Mar-Apr. PMID 22324981.
15. Nunez MI, et al. J Thorac Oncol. High expression of folate receptor alpha in
lung cancer correlates with adenocarcinoma histology and EGFR [corrected]
mutation., 2012 May. PMID 22729036.
16. Pey AL, et al.Human cystathionine β-synthase (CBS) contains two classes
of binding sites for S-adenosylmethionine (SAM): complex regulation of CBS
activity and stability by SAM. Biochem J, 2013 Jan 1. PMID 22985361.
17. Ratanasthien K, Blair JA, Leeming RJ, Cooke WT, Melikian V. Serum
folates in man. J Clin Path 30:438–448,1977.
18. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of
the coordinate regulation by s-adenosylmethionine of the remethylation and
transsulphuration of homocysteine. Am J Clin Nutr 55:131–138, 1992.
19. Silva IH, et al. The impact of GGH -401C&gt;T polymorphism on
cisplatin-based chemoradiotherapy response and survival in cervical cancer.
Gene, 2013 Jan 10. PMID 23107767.
20. Stokstad ELR, Koch J. Folic acid metabolism. Physiol Rev 47:82–116,
1967.

53

21. Trifonova EA, et al. Analysis of the MTHFR gene linkage disequilibrium
structure and association of polymorphic gene variants with coronary
atherosclerosis. Genetika, 2012 Oct. PMID 23270270.
22. Weiner AS, et al.. Role of polymorphic variants of MTR gene A2756G and
SHMT1 gene C1420T in the development of prostatic cancer in residents of the
Western Siberian Region of Russia. Bull Exp Biol Med, 2012 Feb. PMID
22803112.
23. Xu Y, et al. Tumour Biol. High thymidine kinase 1 (TK1) expression is a
predictor of poor survival in patients with pT1 of lung adenocarcinoma., 2012
Apr. PMID 22143937
24. Zampieri BL, et al. BHMT G742A and MTHFD1 G1958A polymorphisms
and Down syndrome risk in the Brazilian population. Genet Test Mol
Biomarkers, 2012 Jun. PMID 22339736.
25. Zhou D, et al. The polymorphisms in methylenetetrahydrofolate reductase,
methionine synthase, methionine synthase reductase, and the risk of colorectal
cancer. Int J Biol Sci, 2012. PMID 22719222.

54

ABSTRACT
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Folate is a water-soluble vitamin B that plays a critical roles in the de novo
nucleotide synthesis, DNA repair, DNA methylation, and cellular growth. By
involved in the one-carbon metabolic pathways, folate influences the thymidine
monophosphate (dTMP) and the purine nucleotides synthesis, consequently
affect the DNA synthesis and repair. Through the one-carbon pathway, the
folate level also influences the DNA methylation, consequently affect the gene
expression.
In this study, we inspected the change of gene expression of 14 genes which
are related to the folate metabolism in two different cell lines. One is MEF cell
line and the other one is BNL-C2 cell line. So that we could figure out the
difference of gene expression change level between the MEF and BNL-CL2 cell
lines when they suffer the folate depletion condition.
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From the result we got, we can know that except from RFC, FPGS , SHMT1and
MTHFD1, other 11 genes all have the similar gene expression change level
between the MEF and BNL-CL2 cell lines when they suffer the folate depletion
condition. The different gene expression of RFC between the two cell lines
might due to liver needs to release the folate derivatives to other body part
where dividing cell regularly such as skin cells. The difference of FPGS
between two cell lines might due to liver is the central organ for folate
homeostasis, the gene expression in liver won't change much even the cells are
suffering folate depletion condition. However, skin cells needs large amount of
folate or its derivatives to support the cell division or cell growth, when the skin
cells suffer the folate depletion condition, skin cells might increase the gene
expression of FPGS to reestablish the folate homeostasis. The difference of
MTHFD1 and SHMT1 between two cell lines might due to liver is not the organ
replicate cells so regularly like the skin cells, when the skin cells suffer the
folate depletion condition, skin cells might increase the gene expression of
MTHFD1

and

SHMT1

to

get

more

tetrahydrofolate

and

5,10-methylene-tetrahydrofolate which are substrates for de novo synthesis of
methionine, thymidylate and purine.
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